SM17, a new IL-17RB-targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis. Lam LH, Li W, Wu WC, Chow KC, et al. Allergy 2024 Apr 9. doi: 10.1111/all.16120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lam LH, Li W, Wu WC, Chow KC, et al. SM17, a new IL-17RB-targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis. Allergy 2024 Apr 9. doi: 10.1111/all.16120.
PMID: 38590291